Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interleukin-2 × Gynecologic × Clear all

Phase

Status

Completed 9 Terminated 6 Recruiting 5 Unknown 3 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Dermatologic 5 Other hematologic neoplasm 4 Lymphoid 2 Thoracic 1 Myeloid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 CNS 1 Breast 1

Conditions

Ovarian Cancer Metastatic 1

Interventions

Paclitaxel 19 Carboplatin 19 Radiotherapy 11 Cisplatin 11 Bevacizumab 9 olaparib 6 Taxes 6 Cyclophosphamide 6 pembrolizumab 5 niraparib 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 dostarlimab 4 aldesleukin 4 Specimen Handling 4 Doxorubicin 4 talazoparib 3 fludarabine 3 Topotecan 3 Radiation 3 Metformin 3 Letrozole 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Fulvestrant 3 Colposcopy 3 veliparib 2 sitravatinib 2 palbociclib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389229 2020-12-16

OVSTAR

Immetacyte Ltd

Phase 1/2 Withdrawn

Ovarian Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡